We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » RefleXion Biology-Guided Radiotherapy Gets Marketing Clearance for Cancer Treatments
RefleXion Biology-Guided Radiotherapy Gets Marketing Clearance for Cancer Treatments
RefleXion Medical’s SCINTIX, a biology-guided radiotherapy that turns cancer cells into “biological beacons” that control radiotherapy delivery to tumors, has received de novo marketing authorization from the FDA to treat lung and bone tumors.